Abstract-Lipoprotein (a) [Lp(a)], is present only in humans, Old World nonhuman primates, and the European hedgehog.Lp(a) has many properties in common with low-density lipoprotein (LDL) but contains a unique protein, apo(a), which is structurally different from other apolipoproteins. The size of the apo(a) gene is highly variable, resulting in the protein molecular weight ranging from 300 to 800 kDa; this large variation may be caused by neutral evolution in the absence of any selection advantage. Apo(a) influences to a major extent metabolic and physicochemical properties of Lp(a), and the size polymorphism of the apo(a) gene contributes to the pronounced heterogeneity of Lp(a). There is an inverse relationship between apo(a) size and Lp(a) levels; however, this pattern is complex. For a given apo(a) size, there is a considerable variation in Lp(a) levels across individuals, underscoring the importance to assess allele-specific Lp(a) levels. Further, Lp(a) levels differ between populations, and blacks have generally higher levels than Asians and whites, adjusting for apo(a) sizes. In addition to the apo(a) size polymorphism, an upstream pentanucleotide repeat (TTTTA n ) affects Lp(a) levels. Several meta-analyses have provided support for an association between Lp(a) and coronary artery disease, and the levels of Lp(a) carried in particles with smaller size apo(a) isoforms are associated with cardiovascular disease or with preclinical vascular changes. Further, there is an interaction between Lp(a) and other risk factors for cardiovascular disease. The physiological role of Lp(a) is unknown, although a majority of studies implicate Lp(a) as a risk factor. Key Words: atherosclerosis Ⅲ genetics Ⅲ blacks Ⅲ lipids L ipoprotein(a) [Lp(a)] was first described Ϸ40 years ago, and interest in this entity is largely derived from its putative role as a cardiovascular risk factor. 1-3 Underlying this concept is the realization that Lp(a) has many properties in common with low-density lipoprotein (LDL), a wellestablished atherogenic factor for coronary artery disease. [2][3][4][5] Thus, the composition of the lipid moiety of Lp(a), including its cholesteryl ester-rich core, is similar to that of LDL, and the density distribution of the lipid moiety of Lp(a) in a given subject closely mirrors that of LDL. 6 Furthermore, like LDL, each particle of Lp(a) has 1 molecule of apolipoprotein B-100 (apo B-100); both apolipoprotein B (apoB) and the lipid core are pro-atherogenic. 7 Also, Lp(a) clearance rates are similar to those for LDL. 8,9 However, Lp(a) contains a unique protein, apolipoprotein(a) [apo(a)], which is structurally different from other apolipoproteins, having a hydrophilic, carbohydrate-rich structure with no amphipathic helices. 5,10,11 Apo(a) is linked to apoB through a single disulfide bond connecting their C-terminal regions [12][13][14][15] (Figure 1).The presence of apo(a) influences to a major extent metabolic and physicochemical properties of Lp(a). 16 -18 Notably, the cysteine residue in apoB involved in ...